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BACKGROUND:  Different  forms  of  chronic  airway
inflammation  may  involve  diverse  pathogenic  ele-
ments.  In  general,  deficient  defence  response  is  a
feature  of  chronic  obstructive  pulmonary  disease
(COPD), whereas distorted immunoregulatory mech-
anisms lead to development of asthmatic symptoms.
In  addition  to  diverse  effector  mechanisms,  the
cellular  and humoral  elements participating  in the
development of immune response may appear to be
different  in  COPD  and  bronchial  asthma  (BA)
patients.
Aims: To evaluate the immunoregulatory properties
of T  cells  and monocytes  in cultures  of peripheral
blood  mononuclear cells  (PBMC)  and  to  determine
the  chosen  cytokine  profiles  in  COPD  and  BA
patients.
Methods: The microcultures of PBMC from COPD and
BA patients were assessed for the T-cell response to
mitogens, saturation of interleukin (IL)-2 receptors,
T-cell suppressive activity and monokine influence on
lymphocyte  proliferation.  Concomitantly,  the  cyto-
kine (IL-1b, interleukin-1 receptor antagonist, tumour
necrosis factor-a, IL-4, IL-6, IL-8) concentrations were
determined in the serum, the broncho-alveolar lavage
fluid and in the culture supernatants.
Results:  The  T-lymphocyte  reactions  (response  to
phytohaemagglutinin, IL-2  receptor saturation, sup-
pressive activity) were lower in BA pateints than in
COPD patients. Reversely, the immunogenic activity
of  monocytes  (IL-1b versus  IL-1ra  production)  was
higher  in  BA  patients  than  in  COPD  patients.  The
highest values of cytokine concentrations were found
in  the  culture  supernatants.  The  concentrations  of
tumour  necrosis  factor-a,  IL-4,  IL-6  and  IL-8  were
significantly higher and the concentration of IL-1ra
was lower in BA patients than in COPD patients.
Conclusion:  The  assessments  of  cellular  immunor-
egulatory  properties  and  cytokine  profiles  in  the
cultures  of  blood  mononuclear  cells  may  prove
helpful for diagnostic and therapeutic discrimination
between BA and COPD patients.
Key words: Asthma, Chronic  obstructive  pulmonary dis-
ease,  Immunopathogenesis,  Cell-mediated  immunoregula-
tory mechanisms, Cytokine profiles
Introduction
Bronchial asthma (BA) and chronic obstructive pul-
monary disease (COPD) have become an increasing
problem  for  contemporary  medicine  and  public
health.  Epidemiologic  data  suggest  that  the  preva-
lence  of  bronchial  hyperreactivity  observed  in
patients with BA and COPD has increasing frequency.
Identification of  factors  and  mechanisms  that have
caused these increases may contribute for invention
of a new preventive strategy to control the inflamma-
tory process in the airways.
Chronic airway  inflammation  may  develop along
different  pathogenic  pathways  responsible  for  inci-
dental  recurrent  bronchial  constriction and  clinical
appearance  of  COPD  or  BA. There  are  some  well-
established  differences  between  the  repertoires  of
cellular  and  humoral  elements  involved  in  both
processes.1–9TCD8 lymphocytes, neutrophils, macro-
phages,  leukotriene  LTB4,  tumour  necrosis factor-a
(TNF-a)  and  interleukin  (IL)-8  are  the  main  repre-
sentatives of the local inflammatory milieau of COPD,
whereas  mast  cells,  basophils,  active  eosinophils,
macrophages, TCD4  cells  of  T  helper  (Th)2 type,
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and  IL-13  comprise  the  immune  inflammatory  ele-
ments characteristic of BA. In contrast to the number
of participating elements, both pathways of immune
response  do  not  result  in  a  final  resolution,  but
contribute to further progression of the inflammatory
state, thus representing profound, although different
in nature, sorts of immune disabilities. If, in general,
deficient defence mechanisms can be estimated as a
pathogenic cause of progression of COPD, the main
reasons  for  occurence  of  BA  generate  rather  from
distorted  immunoregulatory  properties  of  the
immune system.
To gain an immunodiagnostic insight that could help
to  discern  between  COPD  and  BA  patients  who
demonstrate exacerbated bronchospastic symptoms,
we have assessed their blood-derived peripheral blood
mononuclear  cells  (PBMC)  for  immunoregulatory
properties [lymphocyte  responses to  phytohaemag-
glutinin  (PHA) and to concanavalin A (Con A), Con
A-induced  T-cell  suppressive  activity  (SAT  index),
monokine  (interleukin-1  receptor  antagonist/IL-1b)
influence on lymphocyte proliferation (LM index), and
saturation of lymphocyte IL-2 receptors (IL-2 index)],
which  were  tested  in  the  microculture  system.10
Concomitantly, the serum, the broncho-alveolar lavage
(BAL) fluid and the supernatants of cultured PBMC
were  assessed  for  concentrations  of  the  chosen
cytokines (TNF-a, IL-1b, IL-1ra, IL-4, IL-6 and IL-8) to
compare  their  quantities  and  mutual  proportions
depending on the source of the tested samples and on
their origin from COPD or BA patients.
The choice of such a repertoire of immunological
tests was based on the following predictions.
1. The  mononuclear  cell  population  isolated  from
peripheral blood contains both T cells and mono-
cytes  (antigen-presenting  cells)  in  quantities  and
with typical functional immunoregulatory proper-
ties characteristic for the donor. These cells, set up
in  the  culture  and  tested  under  appropriate
experimental conditions,10,11 may deliver in vitro
informations  on  the  actual  functional  state  of
immune cells existing in vivo.
2. The  type  and  the  concentration  of  elaborated
cytokines also characterise the functional state of
immune  cells. The  respective  cytokines  can  be
found in vitro in close vicinity to the responding
cells (in the culture supernatants) or in vivo at the
more distant humoral peripheries from the site of
their production (e.g. in the BAL fluid or in the
blood serum). In this respect, testing sites in the
possibly closest humoral vicinity can be expected
to  yield  the  most  accurate  information  on  the
actual  functional  state  of  a  cellular  sources  of
assessed  cytokines.  For  this  reason,  the  assess-
ments of chosen cytokines were performed con-
comitantly in the serum and in the BAL fluid as
well as in the supernatants of cultured PBMC of
each patient.
3. If the results of the tests performed in the cultures
of PBMC appear to be comparable with the results
of cytokine analysis in the BAL fluid, and therefore
sufficient  for  diagnostic  discrimination  between
COPD and BA patients, the performance of BAL
could be abandoned, in some cases at least, for the
favour  of  PBMC  assessments  that  are  obviously
much less harmful for the patient.
Materials and methods
Patients
The investigations were carried out in the group of 20
patients with COPD (12 men and eight women; age
range, 38–50 years) and in the comparable group of 20
patients with BA (11 men and nine women; age range,
32–45 years) who demonstrated mild exacerbation of
bronchospastic symptoms. They did not receive any
systemic  or  inhaled  corticosteroids  for  at  least  3
months before admission to the study. The diagnosis of
COPD  or  BA  was  established  on  the  grounds  of  a
routine subjective and objective clinical examination,
and  was  confirmed  by  the  appearance  of  atopic
symptoms (positive skin-prick tests to common dust
allergens,  elevated  level  of  total  serum  IgE)  in  BA
patients and by the lack of such symptoms in COPD
patients. They  all  expressed  conscious  consent  for
participation in the study and the investigations have
received approval from the Ethical Commission of the
Central Clinical Hospital of Military School of Medicine
in Warsaw. Before administration of the therapy, the
patients were tested immunologically  and BAL was
performed in all of them.
Immunological tests
PBMC microcultures
PBMC were isolated by density gradient sedimenta-
tion  (1.007g/ml;  Ficoll-Paque  Pharmacia  LKB
Uppsala, Sweden) of heparinised venous blood sam-
ples taken from the patients. After determination of
the  cell  viability,  the  microcultures  were  set up  in
triplicate in  Linbro (Flow-Laboratories, Irvine,  Scot-
land) round-bottomed, 96-well microplates, as descri-
bed previously.10 In brief, the cultures, each contain-
ing 105 cells in 0.2ml of RPMI 1640  supplemented
with  15%  of  inactivated  autologous  serum,  were
incubated at 37°C in an ASSAB incubator (Uppsala,
Sweden) in a humified atmosphere of 5% CO2 in air
for 72h. Respective triplicates of microcultures were
left without stimulation or were stimulated with PHA
(HA16, 0.4mg/culture, optimal dose; Murex Biotech
Ltd., Dartford, UK) or Con A (8mg/culture; Sigma, St
Louis, MO, USA). At 24h, some triplicates of micro-
cultures  were  re-arranged  as  described  else-
where.10,11 For  the  last  18h  of  incubation,  the
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(3HTdR) (specific activity, 5C/mM; Amersham, Chal-
font, UK) in a dose of 0.4mC/culture. After harvesting
the  cultures,  the  measurements  of  incorporated
radioactivity were carried out  in  a Packard Tri-carb
2100 TR liquid scintillation analyser (Packard Instru-
ment Company, Meriden, USA) and the results were
expressed  as  a  mean  value  of  disintegrations  per
minute (dpm) (standard deviation for each triplicate.
The following parameters of T-lymphocyte and mono-
cyte functions were assessed: (a) spontaneous 3HTdR
incorporation, (b) T-cell  response to PHA, (c) T-cell
response to Con A, (d)  the SAT index,  (e)  the IL-2
index, and (f) the LM index.
Cytokine assessments
The samples of the blood serum, the BAL fluid and
the PBMC culture supernatants were collected, frozen
(–70°C)  and  subsequently  tested  by  enzyme-linked
immunosorbent  assay  in  the  universal  microplate
analyser Elx800 (Biokom (Warsaw-Janki), Poland) for
the presence of TNF-a, IL-1b, IL-1ra, IL-4, IL-6 and IL-8
with  the  use  of  respective  Quantikine  kits  (R&D,
Abingdon,  UK).  The  results  were  expressed  as  a
concentration of respective cytokine (pg/ml) in the
tested sample.
The BAL fluid was obtained in the same way in all
the  patients.  Briefly,  about  80ml  of  the  fluid  was
retrieved  from  the  BAL  performed  with  the  three
portions (each of 50ml) of 0.9% NaCl given consec-
utively into the airways during the bronchoscopy. The
retrieved volume of the BAL fluid was centrifuged and
the part of obtained cell-free supernatant (about 3ml)
served  for  cytokine  assessments.  No  detailed  cyto-
logic  analysis  in  this  part  of  BAL  fluid  has  been
performed because only scanty cells or cellular debris
were  present  in  the  sediment.  The  PBMC  micro-
culture supernatants, in which the cytokine measure-
ments  were  performed,  were  collected  from  the
separate  sets  of  non-stimulated,  triplicate  micro-
cultures at 24h of incubation.
The results of performed estimations in the PBMC
cultures,  the  blood  serum  and  the  BAL  fluid  were
compared  between  COPD  and  BA  patients.  The
observed differences of the mean values were ana-
lysed  using  the  Student  t-test  to  estimate  their
statistical significance.
Results
PBMC microcultures
The viability of cells tested at the end of the cultures
remained at the level of 80% of the initial number of
living cells (105) in the culture. The results of the tests
performed in  PBMC microcultures  are presented in
Table  1. The  spontaneous  incorporation  of  3HTdR
was low and similar in the PBMC cultures from COPD
patients  and  from  BA  patients.  In  the  response  to
PHA, the mononuclear cells of  COPD patients pro-
liferated more vigorously [(67.6 ± 10.2) ´ 103dpm/
culture] than the PBMC of BA patients [(49.5 ± 11.1)
´ 103 dpm/culture],  and  the  difference  was  statis-
tically significant (p < 0.01). The cells of both groups
of patients responded well to Con A stimulation and
no  significant  differences  were  observed  between
them.  In  contrast  to  that,  the  Con A-induced  sup-
pressive  activity  of  T  cells  (the  SAT  index)  was
significantly lower (p < 0.01) in BA patients (15.2 ±
3.6) than in COPD patients (22.1 ± 5.2).
The LM index, which represents the competitive
influence  of  IL-1ra  and  IL-1b on  the  lymphocyte
proliferation (see also Table 2) was significantly lower
(p < 0.01) in the PBMC cultures from COPD patients
(8.3 ± 4.1) than in the respective cultures from BA
patients (12.1 ± 6.2). The saturation of IL-2 lympho-
cyte receptors was higher in the COPD group (84 ±
15%) than in the BA group of patients (73 ± 26%), and
the observed difference was statistically significant (p
< 0.02).
Cytokine assessments
The  cytokine  concentrations  found  in  the  blood
serum, the BAL fluid and in the supernatants of PBMC
cultures of COPD and of BA patients are presented in
Table 2.
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Table 1. Response to mitogens [PHA and Con A (dpm ´ 10
3/culture)] and immunoregulatory indices (SAT index, LM index, and
IL-2 receptor saturation) in PBMC microcultures from patients with COPD and BA
Patients PBMC microcultures
Spontaneous
3HTdR
incorporation
PHA Con A SAT
index
LM
index
IL-2
receptor
saturation (%)
COPD (n = 20) 1.4 ± 0.3 67.6 ± 10.2 31.5 ± 4.5 22.1 ± 5.2 8.3 ± 4.1 84 ± 15
BA (n = 20) 1.6 ± 0.4 49.5 ± 11.1 32.7 ± 6.8 15.2 ± 3.6 12.1 ± 6.2 73 ± 26
Statistical significance N.S. < 0.01 N.S. < 0.01 < 0.01 < 0.02
Data presented as mean ± standard deviation. N.S., not significant.Serum samples
The  concentrations  of  cytokines  detected  in  the
serum were low, with the exception of IL-1ra, and the
values of  IL-1ra,  IL-4  and IL-6  found  in  BA patients
were  lower  than  in  COPD  patients. The  observed
differences were statistically significant (p < 0.01).
BAL fluid
The  concentrations  of  cytokines  present  in  the
samples of BAL fluid of the both groups of patients
were distinctly higher than the respective cytokine
concentrations found  in  the  serum. The  exception
was TNF-a, whose concentration in the BAL fluid of
BA  patients  was lower  than  in  the  serum  of  these
patients. The concentrations of TNF-a, IL-1b and IL-4
were significantly lower in BA patients than in COPD
patients, but  the ratio of IL-1ra/IL-1b concentration
was higher in BA patients (38.5 ± 7.4) than in COPD
patients (29.2 ± 3.8). The observed differences were
statistically significant (p < 0.01).
Supernatants of PBMC cultures
The concentrations of TNF-a, IL-1b, IL-1ra, IL-6 and IL-
8  found  in  the  supernatants  of  PBMC  cultures
exceeded considerably the respective values found in
the serum or in the BAL fluid of the both groups of
patients. In  contrast, the concentration of  IL-4  was
higher than in the serum but lower than in the BAL
fluid. The concentration of IL-4 found in BA patients
was significantly higher than that in COPD patients.
Also, the concentrations of TNF-a, IL-6 and IL-8 were
significantly  higher  in  BA  patients  than  in  COPD
patients. No differences were observed between the
concentrations of IL-1b in BA and COPD patients but
the  value  of  IL-ra  was  significantly  lower  in  BA
patients  and,  therefore,  the  ratio  of  IL-1ra/IL-1b
concentration also was lower in BA patients than in
COPD  patients  (2.7  ±  0.6  versus  4.4  ±  0.4,
respectively).
The values of cytokine concentrations found in the
serum,  the  BAL  fluid  and  the  culture  supernatants
could  not  be  compared  directly  because  of  the
different  sources  of  the  sample  origin  and  the
different  methods of  preparation. Nevertheless, the
samples of  the same origin,  which represented the
highest values of cytokine concentration and the most
evident differences between the groups of patients,
could be estimated as particularly valuable for diag-
nostic purposes.
Discussion
The  elevated  total  serum  IgE,  the  presence  of  IgE
specific to common dust allergens and positive results
of  skin-prick  tests  to  the  air  distributed  allergens
(house-dust  mites, cockroaches, pets and  the fungi
alternaria)  are  the  main  diagnostic  features  that
discriminate  the  atopic  asthma  from  the  COPD  in
patients demonstrating incidental symptoms of bron-
chial constriction.8,12–15
The enlisted features represent the final  efectory
elements that generate from a long chain of preceding
immunopathogenic  events  responsible  for  develop-
ment of a chronic inflammatory state in the airways.
Recognition of the nature and the sequence of these
events may be helpful not only for the settlement of a
discriminative  clinical  diagnosis,  especially  in  the
cases with less evident final allergic symptoms, but
also  for  a  better  understanding  of  the  mechanisms
that lead to the airway inflammation.
Between the pathway of the Th2-mediated mecha-
nism  responsible  for  allergic  inflammation  and  the
Th1 mechanism preponderant in a non-allergic inflam-
matory  reaction,  both  qualitative  and  quantitative
differences can be found. They relate to the profile of
cytokines involved and to the actual functional state
of  immunoregulatory  cells,  including T-cell suppres-
sive  activity  and  production by  monocytes of  pro-
inflammatory  (IL-1b)  and  anti-inflammatory  (IL-1ra)
monokines. To gain an immunodiagnostic insight into
these elements, several types of the clinical material
W. Stankiewicz et al.
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Table 2. Concentrations (pg/ml) of chosen cytokines in the serum, the BAL fluid and in the supernatants (SN) of PBMC cultures
from COPD and BA patients
Cytokine COPD patients (n = 20)
Serum BAL fluid SN
BA patients (n = 20)
Serum BAL fluid SN
TNF-a 16.0 ± 7.7
a 20.7 ± 3.5 141.0 ± 32.1 17.5 ± 6.1 13.1 ± 3.7* 169.0 ± 48.6*
IL-1b 15.3 ± 0.9 74.4 ± 11.0 950.0 ± 86.2 13.2 ± 1.7 59.4 ± 15.2* 1020.0 ± 191.2
IL-1ra 449.0 ± 51.7 2172.0 ± 200.8 4230.0 ± 433.1 360.2 ± 64.8* 2290.0 ± 181.0 2800.0 ± 680.4*
IL-4 20.9 ± 1.4 276.5 ± 7.3 79.0 ± 18.3 17.2 ± 1.1* 233.6 ± 17.2* 96.0 ± 26.3*
IL-6 45.6 ± 3.3 423.2 ± 38.0 1392.0 ± 206.4 48.6 ± 5.6 405.0 ± 59.4 2600.0 ± 708.2*
IL-8 25.9 ± 2.5 148.3 ± 13.0 229.0 ± 26.8 19.1 ± 3.8* 164.4 ± 11.3 321.0 ± 38.5*
Data presented as mean ± standard deviation, except a mean ± SEM.
*Statistically significant differences (p < 0.01) between COPD and BA patients for the serum, the BAL fluid and the SN of the PBMC culture,
respectively.can be sampled. The results of our investigations seem
to suggest that, among different  samples, including
blood  serum  and BAL  fluid,  the mononuclear  cells
isolated from  the  blood  and  cultured  under  appro-
priate experimental conditions may deliver the most
accurate  and  comprehensive  informations  on  the
immune mechanisms involved in the development of
airway inflammation. Moreover, the vein puncture is
much  more  convenient  for  the  patients  than  the
traumatic procedure of performed BAL.
The  results  of  our  in  vitro assessments  of  the
functional properties of PBMC found in BA patients
and  in  COPD patients are in  line  with the present
conception  of  a  different  immune  background
accounting for development of allergic or non-allergic
forms of airway inflammation.
In  BA  patients,  the  parameters  representing  the
T-lymphocyte immunocompetence and immunoregu-
latory abilities of a Th1 nature (response to PHA, Con
A-induced  suppressive  activity  and  IL-2  receptor
saturation)  expressed  the  values  that  were  signifi-
cantly  lower  than  the  respective  values  found  in
COPD patients (Table 1).
The values of the LM index, which represent, in a
reciprocal manner, a competitive influence of IL-1ra
and IL-1b on the lymphocyte proliferative response,11
were significantly higher in BA patients than in COPD
patients. The results show the existence of a relative
preponderance of a pro-inflammatory activity of IL-1b
over  an  anti-inflammatory  activity  of  IL-1ra  in  BA
patients. The absolute value of the IL-1ra concentra-
tion found in the supernatants of PBMC cultures of BA
patients was considerably lower (2800.0 ± 680.4pg/
ml) than the respective value found in COPD patients
(4230.0 ± 433.1pg/ml), whereas the concentrations
of IL-1b were similar in the both groups of patients
(Table 2). On the contrary, the values of IL-1b and IL-
1ra concentrations found in the culture supernatants
in  healthy  volunteers,  and  presented in  our  earlier
publication11 were 170 ± 90 and 1900 ± 810pg/ml,
respectively, which produces a relatively high IL-1ra/
IL-1b ratio (11.1  ± 7.5)  and a low value of the LM
index (8.2 ± 2.5).
The assessments of the IL-1ra/IL-1b concentration
ratio within the humoral environment of responding
cells  may  provide  a  diagnostic  insight  into  the
progression of the ongoing immune response and into
the actual stage of the development of inflammatory
process.  In  general,  low  values  of  the  IL-1ra/IL-1b
ratio characterise the progressive phase whereas high
values  mark  the  regressive  phase  of  both  pro-
cesses.11,16The comparison of the observed values of
the LM index suggests that the airway inflammation
was  more  intense  in  BA  patients  than  in  COPD
patients.
The  assessments  of  the  other  cytokines  in  the
supernatants  of  PBMC  cultures  of  BA  and  COPD
patients revealed the existence of differences in the
concentrations  of  TNF-a,  IL-4,  IL-6  and  IL-8.  The
concentrations of these cytokines were considerably
higher in BA patients than in COPD patients. Inter-
estingly, the serum values of TNF-a, IL-4, IL-6 and IL-8
found in COPD and BA patients remained, on average,
at  the  level  accepted  for  healthy  volunteers  (15.6,
31.2, 12.5 and 31.2, respectively, cited after the R&D
Quantikine  kits  producer).  In  contrast  to  that,  the
values  found  in  our  experiments  in  the  culture
supernatants  have  differed  considerably  from  the
values described by the cytokine kits producer as a
characteristic for the blood mononuclear cell culture
supernatants  in  apparently  healthy  volunteers. The
observed differences exceeded significantly the mini-
mal  cytokine  concentrations guaranted  by  R&D  as
detectable (e.g. < 4.4pg/ml for TNF-a, 14pg/ml for IL-
1ra, 0.7pg/ml for IL-6, and 10pg/ml for IL-8).
The present observations confirm the existence of
pathogenic imbalance between the pro-inflammatory
activities of IL-1b and the diminished anti-inflamma-
tory potential of IL-1ra, which could be expected in
BA patients. The IL-1ra/IL-1b concentration ratio was
higher  in  COPD  patients  (4.4  ±  0.4)  than  in  BA
patients  (2.7  ±  0.6),  and  the  difference  was  statis-
tically significant (p < 0.01). In these circumstances,
the elevated concentrations of TNF-a, IL-4, IL-6 and IL-
8  could result  from  the increased activity of  IL-1b,
which strongly stimulates the production of numer-
ous  pro-inflammatory  agents,  including  prostaglan-
dins, cytokines and chemokines.16–18
Two cytokines, IL-4 and IL-5, which belong to the
Th2 pathway  of  the  immune  response,  play  an
essential role in the development of allergic inflamma-
tion. IL-5 induces terminal differentiation of eosino-
phils and contributes to the airway eosinophilia,19,20
whereas IL-4 stimulates the proliferation of B lympho-
cytes, the production of immunoglobulins and indu-
ces  the  switch  of  the  produced  immunoglobulins
from IgM to IgE class.21,22The assessments of the one
of these cytokines were included in our study and the
results show that the concentrations of IL-4 found in
the supernatants of PBMC cultures were significantly
higher in BA patients than in COPD patients. The fact
that the concentrations of  IL-4  found  in  the super-
natants of PBMC cultures was lower than in the BAL
fluid in both groups of patients could be attributed to
the procedure of PBMC isolation from the vein blood.
During  this  procedure,  the  mast  cells  and  the
basophils,  which  are  important  but  not  exclusive
producers  of  IL-4,  could  be  lost  on  the  density
gradient.
In conclusion, the results of the present investiga-
tions indicate that in addition to the routine allergic
tests  that  discriminate  between  BA  and  COPD  in
patients with the symptoms of bronchial constriction,
the assessments of  PBMC performed in  the culture
may deliver important information on the nature and
the  progression  of  the  airway  inflammation.  This
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egulatory properties of the immune system and the
cytokine profile assessed in the culture supernatants,
may prove to be helpful for discrimination between
the allergic and non-allergic inflammation, and may
contribute to the development of a new preventive
and  therapeutic  strategy  to  control  the  course  of
inflammation in the airway.
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